Skip to main navigation Skip to search Skip to main content

Correction to: Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma (Journal of Cancer Research and Clinical Oncology, (2022), 148, 7, (1703-1708), 10.1007/s00432-021-03911-0)

  • Sheba Medical Center at Tel Hashomer
  • University of Pennsylvania
  • Tel Aviv University
  • Thomas Jefferson University
  • Harvard University

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

In the original version of this article, the author name “Lawrence YR” was incorrectly written as “Lawerence YR”. This is corrected in the original article now.

Original languageEnglish
Pages (from-to)1709
Number of pages1
JournalJournal of Cancer Research and Clinical Oncology
Volume148
Issue number7
DOIs
StatePublished - Jul 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Correction to: Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma (Journal of Cancer Research and Clinical Oncology, (2022), 148, 7, (1703-1708), 10.1007/s00432-021-03911-0)'. Together they form a unique fingerprint.

Cite this